Search for Elan Corp PLC and
    1. January 15, 2014

      Trial hears doctor ‘flabbergasted’ by Martoma’s drug knowledge

      A doctor briefed on a confidential Alzheimer’s drug trial testified on Wednesday that he was “flabbergasted” that Mathew...

    2. January 5, 2014

      Former SAC manager resolute as trial poised to start

      When prosecutors open their trial this week against Mathew Martoma, a former SAC Capital portfolio manager accused of...

    1. August 25, 2013

      Amgen’s $10.5bn takeover of Onyx approved by both boards

      Amgen said on Sunday night that its takeover of Onyx, the US cancer drug developer, at $125 a share had been approved by...

    2. August 2, 2013

      Better ways to play the merger mania

      Mega mergers are back. This week, advertising groups Omnicom and Publicis announced a $35bn tie-up. Just a day or two...

    3. July 30, 2013

      US biotech stocks ride wave of investor euphoria

      Biotechnology companies are raising money at the fastest rate since the dotcom boom, underscoring the renewed appetite for...

    4. July 29, 2013

      Publicis gains as ‘merger of equals’ buoys European media

      Shares in Publicis, the French advertising agency that has plans to merge with US rival Omnicom, climbed as bid news helped...

    5. July 29, 2013

      Deals fail to lift US stocks

      Deal news was responsible for the two biggest movers on the S&P 500 on Monday, as advertising company Interpublic Group led...

    6. July 29, 2013

      Perrigo / Elan: tax shopping

      Remember the quaint old days, when mergers aimed for cost savings? Ah, the deals of yesteryear. It is all about taxes now....

    7. FT Alphaville

      July 29, 2013

      The (early) Lunch Wrap

      Good morning New York, FT ALPHAVILLE And Shibor’s off again… Izzy notes another pick up in Shibor and wonders if there might...

    8. July 29, 2013

      Perrigo to buy Elan for $8.6bn as it eyes aid of Irish tax system

      Perrigo has agreed to buy Ireland-based Elan Corp for $8.6bn in a cash-and-shares deal that will provide the US generic...

    9. July 28, 2013

      GLG strategy feeds off ‘fear and greed’ in equity markets

      GLG Partners’ Pierre Lagrange has increased his gross exposure to the equity market as his conviction about a positive...

    10. FT Alphaville

      July 19, 2013

      "Edge", SEC v Steve Cohen edition

      Friday was a very very hot day on the East Coast. We wonder if they’re staying cool on SAC’s trading floor this afternoon…...

    11. June 27, 2013

      Ireland’s Green Reit seeks to raise €200m

      Green Reit, a newly established Irish property company, is planning to raise €200m in a flotation on the Dublin and London...

    12. June 21, 2013

      Bid talk lifts Nokia and Kabel amid European equity losses

      Losses for financial stocks and carmakers were at the heart of European equity market weakness this week but bid speculation...

    13. June 20, 2013

      Bid talk gives battered stocks a touch of Elan

      Snippets of merger talk emerged to provide slight relief from the heavy selling in European stocks seen across all markets...

    14. June 20, 2013

      Disney lower as Fed fallout hits US stocks

      Walt Disney shares fell 3.7 per cent to $61.98 after Goldman Sachs removed the stock from its “conviction buy” list, reports...

    15. June 18, 2013

      Elan / Royalty Pharma: time out

      Just as the fat lady was about to sing, her microphone got switched off. That is the outcome, for the moment, of Royalty...

    16. June 18, 2013

      Royalty Pharma abandons bid for Elan

      Royalty Pharma has abandoned its hostile $8bn bid for Elan, leaving the future of the Irish pharmaceutical group unclear...

    17. June 17, 2013

      Elan shareholders support buyback

      Royalty Pharma’s $6.7bn hostile bid for Elan was set to lapse on Monday after shareholders created a stalemate, by approving...

    18. June 14, 2013

      Elan opens formal sale process

      Elan, the Irish pharmaceutical business facing a $6.7bn hostile bid from Royalty Pharma, said on Friday it was putting...

    19. June 13, 2013

      Royalty suffers setback in Elan poll

      Royalty Pharma’s hostile $6.7bn takeover for Dublin-based Elan received a sharp setback on Thursday as the US group’s...

    20. June 13, 2013

      Italian banks lead Eurofirst recovery

      Turbulence in Europe’s equity markets kept investors on their toes as sharp opening losses gave way in afternoon trade, with...

    21. June 13, 2013

      Elan/Royalty Pharma: drug war

      Talk about missing the wood for the trees. Royalty Pharma’s hostile takeover attempt for Dublin-based Elan Corp looks to be...

    22. June 11, 2013

      Royalty accuses Elan of misleading shareholders over vote

      Royalty Pharma has accused Dublin-based Elan of misleading shareholders over voting procedures pivotal to its $6.7bn hostile...

    23. June 11, 2013

      Lombard: IAG fails to electrify with promise of jam tomorrow

      “O’er the wires the electric message came – he is no better, he is much the same!” The words of rotten Victorian poet Alfred...

    24. June 10, 2013

      Elan boosted by talk of counterbid

      Gains for a number of drugmakers and engineering companies helped ensure the fall on the pan-European index was kept to a...

    25. June 7, 2013

      Royalty Pharma raises Elan offer

      The bitter battle for Elan intensified on Friday after private equity group Royalty Pharma raised its all-cash offer for the...

    26. June 4, 2013

      Elan turns to courts to block hostile bid from Royalty Pharma

      Elan, the Irish-based speciality drug company, claimed its shareholders would be drawn into a “shadowy web of hedge funds”...

    27. May 31, 2013

      Elan / Royalty Pharma: number crunchers

      Every takeover should be finally decided on the basis of valuation. So the battle between Royalty Pharma and Elan Corp could...

    28. May 27, 2013

      Biotech: it’s back

      If you are an investor in Celgene you can stop reading now. You are already on your own private island, bought with some of...

    29. May 24, 2013

      European lenders unloved amid growth fears

      European markets reversed much of their May gains this week as investors sold out of equities amid global growth concerns....

    30. May 20, 2013

      Elan steps up fight against Royalty Pharma bid

      Royalty Pharma, the US private equity group, stepped up the pressure on Elan with an improved $12.50-a-share cash offer,...

    31. May 16, 2013

      Elan rejects Royal Pharma’s $5.7bn bid

      Elan, the Irish drug company, has formally rejected as “grossly inadequate” Royalty Pharma’s $5.7bn takeover bid. Elan also...

    32. May 13, 2013

      Elan: two can play

      Sometimes, imitation is not meant to be the sincerest form of flattery. In its attempt to escape the clutches of Royalty...

    33. May 13, 2013

      Elan seeks to weaken hostile bid with $1bn Theravance deal

      Elan, the Irish drug company facing a hostile bid from Royalty Pharma, plans to pay $1bn to buy the rights for four...

    34. April 19, 2013

      Letter from Lex – merger Monday

      Merger Monday they called it this week, and you could hear the mergers and acquisitions bankers squealing with joy. First...

    35. April 18, 2013

      Elan reveals results of $1bn share buyback

      Elan, the Irish drug company at the centre of a hostile takeover bid, announced the results of a share buyback that some...

    36. April 15, 2013

      Elan / Royalty Pharma: win-win

      Here is a good one for the textbooks. Company A reckons that discovering and producing drugs is a mug’s game. Too many...

    37. April 15, 2013

      Royalty Pharma raises offer for Elan

      Royalty Pharma has increased its offer for Elan , the Irish pharmaceutical business, to up to $12 a share with the launch of...

    38. April 10, 2013

      BofA hires ex-Goldman partner in M&A role

      Bank of America Merrill Lynch has hired former Goldman Sachs banker Luigi Rizzo to lead its mergers and acquisitions...

    Search for Elan Corp PLC and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Lex discusses what is at stake in takeover saga...
      June 13, 2013

      Lex discusses what is at stake in takeover saga

    2. Lex on Royalty Pharma's $6.6bn indicative bid for Elan...
      February 25, 2013

      Lex on Royalty Pharma's $6.6bn indicative bid for Elan